Examination of the importance of RUNX category in EGFR wild-type non-small cell lung cancer

被引：0
|
作者：
Kobayakawa, Atsushi [1 ]
Takeda, Kanako [1 ]
Masuda, Tatuya [1 ]
Yanagida, Yohei [1 ]
Obi, Natsuno [1 ]
Sakuramoto, Naoya [1 ]
Hada, Asuka [1 ]
Horiuchi, Ayaka [1 ]
Takeda, Mizuho [1 ]
Sasaki, Asami [1 ]
Matsuo, Hidemasa [2 ]
Sugiyama, Hiroshi [3 ]
Adachi, Souichi [2 ]
Kamikubo, Yasuhiko
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Hum Hlth Sci, Kyoto, Japan
[2] Kyoto Univ, Dept Human Hlth Sci, Kyoto, Japan
[3] Kyoto Univ, Grad Sch Sci, Dept Chem, Kyoto, Japan
来源：
CANCER SCIENCE | 2021年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OE14-7-6
引用
收藏
页码：445 / 445
页数：1
相关论文
共 50 条
  • [21] Absence of TTF-1 Immunoreactivity Can Predict EGFR Wild-Type in Non-Small Cell Lung Cancer (NSCLC)
    Bosdet, I.
    Young, S. S.
    Ali, R. H.
    McNeil, B. K.
    Wong, C.
    Garbutt, K.
    Karsan, A.
    Ionescu, D. N.
    [J]. MODERN PATHOLOGY, 2012, 25 : 474A - 474A
  • [22] Activity of Pemetrexed on Wild-Type and Unknown Status EGFR Genes with Brain Metastases from Non-Small Cell Lung Cancer
    Fan, Y.
    Yu, X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2090 - S2090
  • [23] Gene-expression profiles predict sorafenib efficacy in wild-type EGFR non-small cell lung cancer (NSCLC)
    Saintigny, Pierre
    Blumenschein, George R.
    Diao, Lixia
    Wang, Jing
    Coombes, Kevin
    Liu, Suyu
    Kim, Edward
    Tsao, Anne
    Herbst, Roy
    Alden, Christine
    Lee, Jack J.
    Tang, Ximing
    Stewart, David
    Kies, Merrill
    Fossella, Frank
    Tran, Hai
    Mao, Li
    Hicks, Marshall
    Erasmus, Jeremy
    Gupta, Sanjay
    Girard, Luc
    Peyton, Michael
    Davis, Suzanne
    Lippman, Scott
    Hong, Waun Ki
    Minna, John
    Wistuba, Ignacio
    Heymach, John
    [J]. CANCER RESEARCH, 2012, 72
  • [24] Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, L.
    Gray, J.
    Harb, W.
    Doebele, R.
    Modiano, M.
    Jackman, D.
    Baggstrom, M.
    Atmaca, A.
    Felip, E.
    Provencio, M.
    Cobo Dols, M.
    Adiwijaya, B.
    Kuesters, G.
    Kamoun, W.
    Andreas, K.
    Pipas, J.
    Santillana, S.
    Cho, B. C.
    Park, K.
    Shepherd, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S596 - S596
  • [25] Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, Lecia, V
    Gray, Jhanelle Elaine
    Harb, Wael A.
    Lopez-Chavez, Ariel
    Doebele, Robert C.
    Modiano, Manuel R.
    Jackman, David Michael
    Baggstrom, Maria Quintos
    Atmaca, Akin
    Felip, Enriqueta
    Provencio, Mariano
    Cobo, Manuel
    Adiwijaya, Bambang
    Kuesters, Geoffrey
    Kamoun, Walid S.
    Andreas, Karen
    Pipas, J. Marc
    Santillana, Sergio
    Cho, Byoung Chul
    Park, Keunchil
    Shepherd, Frances A.
    [J]. ONCOLOGIST, 2019, 24 (08): : 1095 - 1102
  • [26] Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer
    Peng, Xiao-Xiao
    Yu, Ruoying
    Wu, Xue
    Wu, Shu-Yu
    Pi, Can
    Chen, Zhi-Hong
    Zhang, Xu-Chao
    Gao, Cun-Yi
    Shao, Yang W.
    Liu, Li
    Wu, Yi-Long
    Zhou, Qing
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
  • [27] Absence of TTF-1 Immunoreactivity Can Predict EGFR Wild-Type in Non-Small Cell Lung Cancer (NSCLC)
    Bosdet, I.
    Young, S. S.
    Ali, R. H.
    McNeil, B. K.
    Wong, C.
    Garbutt, K.
    Karsan, A.
    Ionescu, D. N.
    [J]. LABORATORY INVESTIGATION, 2012, 92 : 474A - 474A
  • [28] Pan-HER inhibition in EGFR wild-type non-small-cell lung cancer
    Peters, Solange
    Smit, Egbert
    [J]. LANCET ONCOLOGY, 2014, 15 (12): : 1289 - 1290
  • [29] A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer Cancer
    Minemura H.
    Yokouchi H.
    Azuma K.
    Hirai K.-I.
    Sekine S.
    Oshima K.
    Kanazawa K.
    Tanino Y.
    Inokoshi Y.
    Ishii T.
    Katsuura Y.
    Oishi A.
    Ishida T.
    Munakata M.
    [J]. BMC Research Notes, 8 (1)
  • [30] Concurrent Thoracic Radiotherapy and Tyrosine Kinase Inhibitors for Wild-Type EGFR Patients with Locally Advanced Non-Small Cell Lung Cancer
    Zheng, Zhi S.
    Xia, Bing
    Xie, Rui F.
    Li, Xia D.
    Zhu, Jue
    Wu, Shi X.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S548 - S548
12345